CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,989 | -16.6% | 86,425 | +40.2% | 0.00% | – |
| Q2 2023 | $35,945 | +1.6% | 61,656 | 0.0% | 0.00% | – |
| Q1 2023 | $35,378 | +86187.8% | 61,656 | 0.0% | 0.00% | – |
| Q4 2022 | $41 | -100.0% | 61,656 | -0.3% | 0.00% | – |
| Q3 2022 | $90,000 | +36.4% | 61,816 | 0.0% | 0.00% | – |
| Q2 2022 | $66,000 | -63.1% | 61,816 | +4.9% | 0.00% | – |
| Q1 2022 | $179,000 | -21.5% | 58,934 | 0.0% | 0.00% | – |
| Q4 2021 | $228,000 | -26.5% | 58,934 | 0.0% | 0.00% | – |
| Q3 2021 | $310,000 | +3.0% | 58,934 | +15.9% | 0.00% | – |
| Q2 2021 | $301,000 | +103.4% | 50,860 | +143.3% | 0.00% | – |
| Q1 2021 | $148,000 | – | 20,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 462,659 | $1,411,000 | 0.58% |
| Sio Capital Management, LLC | 422,598 | $1,289,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $1,550,000 | 0.22% |
| Affinity Asset Advisors, LLC | 400,000 | $1,220,000 | 0.20% |
| Atom Investors LP | 31,385 | $96,000 | 0.04% |
| Ikarian Capital, LLC | 104,741 | $319,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 514,780 | $1,570,000 | 0.01% |
| PURA VIDA INVESTMENTS, LLC | 77,568 | $237,000 | 0.01% |
| Point72 Asset Management, L.P. | 230,000 | $702,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 58,934 | $179,000 | 0.00% |